Clinical Trial Update: Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating avelumab plus azacitidine for refractory or relapsed acute myeloid leukemia (AML) arising from prior myelodysplastic syndrome; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Arising From Prior Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Avelumab (avelumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-10-22